Prevalence of antibiotic-resistant enterobacteria in patients with liver cirrhosis

Recruiting

• Conditions: K74; Fibrosis and cirrhosis of liver

• Registration Number: DRKS00028873
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-06
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients with liver cirrhosis (any Child stage);
For the prophylaxis group: taking antibiotic prophylaxis for at least 4 weeks
weeks

Exclusion Criteria

lack of consent to participate in the study,
Age < 18 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence (%) of antibiotic-resistant enterobacteria per patient on prophylaxis<br>(rectal swab)

Secondary Outcome Measures

Name	Time	Method
Description of species identifications<br>Description of the resistance mechanisms of the resistant isolates<br>Rate of occurrence of infections with antibiotic-resistant pathogens three months before and after study enrollment